The history of the development of the important anticancer drug taxol (1) i
s briefly described, and recent studies of its chemistry and tubulin-bindin
g conformation are then presented. Topics discussed include side chain atta
chment to baccatin III (3a), the effect of oxygenation of the taxane ring s
ystem on bioactivity, the importance of the oxetane ring for bioactivity, t
he synthesis of a C-6/C-4 bridged analogue, and the conformation of the sid
e chain when taxol is bound in a complex with polymerized tubulin.